|
Market Closed -
Other stock markets
|
After hours 16:46:38 | |||
| 83.23 USD | +1.17% |
|
86.07 | +3.41% |
| Market Cap | 9.76B 8.47B 7.9B 7.26B 13.73B 928B 13.88B 93.14B 36.41B 464B 36.65B 35.84B 1,537B | P/E 2026 * |
12.3x | P/E 2027 * | 9.47x |
|---|---|---|---|---|---|
| Enterprise Value | 11.08B 9.62B 8.97B 8.24B 15.59B 1,054B 15.76B 106B 41.34B 527B 41.61B 40.7B 1,746B | EV / Sales 2026 * |
6.27x | EV / Sales 2027 * | 4.97x |
| Free-Float |
98.94% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Halozyme Therapeutics, Inc.
| 1 day | +1.17% | ||
| 1 week | -0.26% | ||
| Current month | +0.84% | ||
| 1 month | +3.03% | ||
| 3 months | +28.90% | ||
| 6 months | +6.80% | ||
| Current year | +23.67% |
| 1 week | 81.21 |  | 83.96 |
| 1 month | 73.89 | | 84.44 |
| Current year | 61.32 | | 84.44 |
| 1 year | 59.38 | | 84.44 |
| 3 years | 32.83 | | 84.44 |
| 5 years | 29.85 | | 84.44 |
| 10 years | 8.18 | | 84.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
Helen Torley
CEO | Chief Executive Officer | 63 | 2014-01-05 |
David Ramsay
DFI | Director of Finance/CFO | 61 | 2013-04-30 |
| Director of Finance/CFO | - | 2026-06-07 |
| Director | Title | Age | Since |
|---|---|---|---|
Matthew Posard
BRD | Director/Board Member | 59 | 2013-03-27 |
Helen Torley
BRD | Director/Board Member | 63 | 2014-01-05 |
| Chairman | 61 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/8/26 | Fiscal year | Chief Executive Officer | 5,769 | 0.0049% | ||
| 7/1/26 | Free | Executive/Senior Manager | 56,055 | 0.0473% | ||
| 7/1/26 | Free | Chief Financial Officer | 168,986 | 0.1425% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.17% | -0.26% | +38.74% | +96.25% | 9.76B | |
| +0.18% | -2.90% | +60.28% | +21.90% | 316B | |
| +2.74% | +3.25% | +36.58% | -10.82% | 71.26B | |
| -2.52% | -7.85% | -5.13% | -9.85% | 8.4B | |
| +1.79% | -2.56% | -14.93% | -15.56% | 4.29B | |
| +1.63% | +3.89% | -33.63% | +6.86% | 3.83B | |
| +3.58% | -3.68% | -11.95% | +17.59% | 3.5B | |
| -5.98% | -9.39% | +16.73% | +34.40% | 2.68B | |
| -0.82% | +5.69% | -0.60% | -2.90% | 2.26B | |
| -1.68% | +1.27% | -23.00% | -16.16% | 1.77B | |
| Average | -0.01% | +0.44% | +6.31% | +12.17% | 42.33B | |
| Weighted average by Cap. | +0.64% | -1.61% | +51.34% | +16.72% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.77B 1.53B 1.43B 1.31B 2.49B 168B 2.51B 16.87B 6.6B 84.05B 6.64B 6.49B 279B | 2B 1.74B 1.62B 1.49B 2.82B 191B 2.85B 19.13B 7.48B 95.32B 7.53B 7.36B 316B |
| Net income | 812M 705M 657M 604M 1.14B 77.24B 1.15B 7.75B 3.03B 38.61B 3.05B 2.98B 128B | 1.03B 898M 837M 769M 1.45B 98.37B 1.47B 9.87B 3.86B 49.18B 3.88B 3.8B 163B |
| Net Debt | 1.32B 1.15B 1.07B 984M 1.86B 126B 1.88B 12.62B 4.93B 62.88B 4.97B 4.86B 208B | 205M 178M 166M 152M 288M 19.49B 291M 1.96B 764M 9.74B 769M 752M 32.28B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-04 | US$83.23 | +1.17% | 1,475,952 |
| 26-08-03 | US$82.27 | -0.33% | 1,367,693 |
| 26-07-31 | US$82.54 | -0.91% | 1,565,028 |
| 26-07-30 | US$83.30 | +0.02% | 2,135,849 |
| 26-07-29 | US$83.28 | -0.20% | 1,634,260 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HALO Stock
Select your edition
All financial news and data tailored to specific country editions
